Weight loss drugs like Ozempic and Wegovy have become extremely popular in the last several years. But these drugs are creating problems for anesthesiologists, so much so that new clinical guidelines have been released by the American Society of Anesthesiologists.

Made in collaboration with the @AnesthesiaPatientSafety Foundation, a nonprofit organization with a fantastic newsletter on updates in the field of anesthesiology. Sign up here: https://www.apsf.org/apsfnewsletter/

Follow APSF on social media:
● Facebook:   / apsforg  
● Instagram:   / apsforg  
● Twitter:   / apsforg  
● LinkedIn:   / anesthesiapatientsafetyfoundationapsf  
● TikTok:   / apsforg  

Studies cited:
● Ultrasound study by Sherwin et. al.: https://link.springer.com/article/10....
● GLP1 agonists & reduced mortality by Kristensen et. al.: https://pubmed.ncbi.nlm.nih.gov/31422...
● APSF case reports: https://www.apsf.org/article/areseri...
● ASA guideline update: https://www.asahq.org/aboutasa/newsr...

0:00 Start
0:34 What are these drugs
2:36 Anesthesia & the stomach
3:40 Concerning case reports
4:53 New guidelines

Music:
Subtle Swagger by Ron Gelinas:   / atmosphericmusicportal  

The information in this video is not intended nor implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained in this video is for general information purposes only and does not replace a consultation with your own doctor/health professional.

#Anesthesiology #Residency #MedicalSchool